Cargando…
Development and Implementation of a Double-Blind Corticosteroid-Tapering Regimen for a Clinical Trial
We describe the design and operationalization of a blinded corticosteroid-tapering regimen for a randomized trial of tocilizumab in giant cell arteritis (GCA). To our knowledge, no clinical trial in any disease has ever employed a blinded corticosteroid-tapering regimen, but this was necessary to th...
Autores principales: | Collinson, Neil, Tuckwell, Katie, Habeck, Frank, Chapman, Monique, Klearman, Micki, Stone, John H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387940/ https://www.ncbi.nlm.nih.gov/pubmed/25878667 http://dx.doi.org/10.1155/2015/589841 |
Ejemplares similares
-
Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial
por: Strand, Vibeke, et al.
Publicado: (2019) -
Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis
por: Gabay, Cem, et al.
Publicado: (2016) -
Glucocorticoid Dosages and Acute‐Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab
por: Stone, John H., et al.
Publicado: (2019) -
Relapse of SARS upon tapering corticosteroid
por: Chien, Jung-Yien, et al.
Publicado: (2004) -
Oral Corticosteroids Tapering in Severe Asthma
por: Boulet, Louis-Philippe, et al.
Publicado: (2021)